BioNTech SE (BNTX) Capital Expenditures Growth (1y) (2019 - 2025)
BioNTech SE (BNTX) Capital Expenditures Growth (1y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
BioNTech SE |
27.38 Bn |
10.07 Bn |
668.28 Mn |
-3.37% |
| Date | Value |
|---|
| Dec 31, 2025 |
-3.37% |
| Sep 30, 2025 |
47.51% |
| Jun 30, 2025 |
67.85% |
| Mar 31, 2025 |
19.06% |
| Dec 31, 2024 |
21.07% |
| Sep 30, 2024 |
-38.05% |
| Jun 30, 2024 |
-30.39% |
| Mar 31, 2024 |
-30.99% |
| Dec 31, 2023 |
35.30% |
| Sep 30, 2023 |
26.27% |
| Jun 30, 2023 |
2.87% |
| Mar 31, 2023 |
1.98% |
| Dec 31, 2022 |
-209.20% |
| Sep 30, 2022 |
24.40% |
| Jun 30, 2022 |
-141.53% |
| Mar 31, 2022 |
-189,090,564.66% |
| Dec 31, 2021 |
-149,419,940.80% |
| Mar 31, 2021 |
100.00% |
| Dec 31, 2020 |
-100.00% |
| Dec 31, 2019 |
274.26% |
